Clinical Trial Update: Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating beta-blockers for treatment of renal angiomyolipomas in tuberous sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Angiomyolipoma
• Tuberous Sclerosis Complex

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Renal Angiomyolipomas, Tuberous Sclerosis | Phase 2 | Status: COMPLETED